PVG.L Regulatory News (PVG)

30 Nov 2007 12:35

Ark Therapeutics Group PLC30 November 2007 Ark Therapeutics Group plc (the "Company") 30 November 2007 Directors' shareholdings The Company announces that, following admission to listing on the Official Listand to trading on the London Stock Exchange's main market for listed securitiesearlier today of 35,636,289 new Ordinary Shares of 1 pence each in the Company("Ordinary Shares") issued pursuant to the Company's Placing and Open Offerannounced on 6 November 2007, the Company has been informed today of thefollowing dealings by certain of its Directors: Director Number of Ordinary Resultant holding of Percentage of enlarged issued share Shares acquired* Ordinary Shares capital following the Placing and Open Offer Dennis Turner 12,024 155,026 0.077Dr Nigel Parker 3,206 2,894,579 1.433Martyn Williams 3,206 551,310 0.273David Prince 4,721 16,486 0.008 * All Ordinary Shares acquired at 105 pence each. Enquiries: Ark Therapeutics Group plc Tel: 020 7388 7722Nick Plummer, Company Secretary This information is provided by RNS The company news service from the London Stock Exchange